Smokeless tobacco products not a safe option, won't help smokers quit

American Heart Association policy statement

2010-09-13

(Press-News.org) Smokeless tobacco products should not be used as an alternative to cigarettes or for smoking cessation due to the risk of addiction and return to smoking, according to an American Heart Association policy statement. Smokeless tobacco products such as dry and moist snuff as well as chewing tobacco may also increase the risk of fatal heart attack, fatal stroke and certain cancers, according to the statement published online in Circulation: Journal of the American Heart Association. "No tobacco product is safe to consume," said Mariann Piano, Ph.D., lead writer of the statement and a professor in the Department of Biobehavioral Health Science at the University of Illinois at Chicago. The statement also addresses a controversy over whether smokeless tobacco product use is a "safer" alternative to smoking. The idea that smokeless tobacco products are preferable to cigarettes is based in part on the Swedish experience where there was a significant decrease in smoking among Swedish men between 1976 and 2002 which corresponded to an increase in the use of smokeless tobacco. However, the opposite was true in a recent United States study which found no reduction in smoking rates among people using smokeless tobacco products. For people trying to quit smoking, nicotine replacement therapy (nicotine gum or a nicotine-releasing patch placed on the skin) is a safer alternative compared to using smokeless tobacco products. Clinical studies have found no increased risk of heart attack or stroke with either type of nicotine replacement therapy. As smoke-free air laws become common in the U.S., smokeless tobacco products have been marketed as a situational substitute ("pleasure for whenever") for cigarette smoking when smoking is prohibited. "Smokeless tobacco products are harmful and addictive – that does not translate to a better alternative," Piano said. Smokeless tobacco also is being used more by teenage boys, according to the statement. The Food and Drug Administration issued a final regulation related to the Tobacco Control Act that became effective June 22 that prohibits the sale of tobacco products to anyone younger than 18 years. "Scientists and policy makers need to assess the effect of "reduced risk" messages related to smokeless tobacco use on public perception, especially among smokers who might be trying to quit," said Piano. INFORMATION:

Co-authors are Neal L. Benowitz, M.D.; Garret A. FitzGerald, M.D.; Susan Corbridge, Ph.D., A.P.N., ACNP; Janie Heath, Ph.D.; Ellen Hahn, Ph.D.; Terry F. Pechacek, Ph.D.; George Howard, D.P.H. Author disclosures are on the manuscript.

ELSE PRESS RELEASES FROM THIS DATE:

Signaling hope for polycystic kidney disease

2010-09-13

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disease that results in chronic kidney failure. Although the genes responsible for ADPKD have been identified (PKD1, PKD2), relatively little is known about how mutations in these genes promote cyst growth molecularly. In this paper, scientists at Children's Hospital in Boston, lead by Jordon Kreidberg, investigated the signaling pathways that go awry in the disease using mouse kidney epithelial cells in which Pkd1 was genetically deleted. They found that the protein c-Met was hyperactive in Pkd1-deficient ...

'Hi-JAK-ing' cancer by inhibiting Jak2

2010-09-13

Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy. Thus far, however, JAK2 inhibition strategies have had limited efficacy and have been accompanied by significant toxicity. In this paper, Ross Levine and his group at the Memorial Sloane Kettering ...

JCI online early table of contents: Sept. 13, 2010

2010-09-13

EDITOR'S PICK Hi-JAK-ing Cancer by Inhibiting Jak2 Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy. Thus far, however, JAK2 inhibition strategies have had limited efficacy and have been accompanied by significant toxicity. In this paper, Ross ...

Exosomal release of beta-catenin may explain why CD82 and CD9 suppress tumor metastasis

2010-09-13

Researchers reveal a new way in which cells restrain beta-catenin and potentially suppress tumor metastasis: the protein can be ejected from cells in small vesicles called exosomes. The study appears online on September 13 in the Journal of Cell Biology (www.jcb.org). Beta-catenin is a central component of the Wnt signaling pathway that controls cell proliferation and differentiation. Activation of the Wnt pathway stabilizes beta-catenin, allowing it to move into the cell nucleus and control the expression of many different genes. Michael Caplan's group at Yale University ...

Enlarged hearts in women shrink faster than those in men after aortic valve replacement

2010-09-13

Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to research reported in a surgical supplement of Circulation: Journal of the American Heart Association. Men's slower heart-size regression times may be attributable to genetic differences that cause the heart to develop more fibrous tissue after surgery because of narrowed heart valves, a condition known as aortic stenosis. "We show for the first time that elderly women and men differ in their gene expression related to fibrous ...

New metabolic markers may predict preeclampsia in early pregnancy

2010-09-13

An international team of scientists and physicians used a combination of sophisticated emerging technologies and data analysis to detect 14 simple metabolites with high accuracy to predict in early pregnancy which women are at risk of developing preeclampsia in later pregnancy, according to a study reported in Hypertension: Journal of the American Heart Association. Currently there is no predictive test for the condition and no cure other than delivery of the baby. Preeclampsia is a life-threatening condition characterized by high blood pressure and high levels of protein ...

Available physician characteristics may not help patients find high-quality care

2010-09-13

Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. "To improve the quality of care received by their beneficiaries, some health plans use physician report cards and tiered physician networks to steer their members toward physicians who provide high-quality care. However, most patients do not have access to ...

Diet/exercise intervention for patients at risk for heart disease improves quality of life

2010-09-13

A lifestyle intervention incorporating exercise training and diet counseling in primary health care settings appears to improve quality of life among adults at moderate to high risk for heart disease and appears cost-effective compared to standard care, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Most individuals in developed countries do not reach recommended levels of physical activity, and are thus at higher risk of illness and death, according to background information in the article. "Extensive ...

Protein-based biomarkers in blood serum could classify individuals with Alzheimer's disease

2010-09-13

An initial analysis suggests that biomarkers in blood serum can be combined with clinical information to accurately classify patients with Alzheimer's disease, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals. "There is clearly a need for reliable and valid diagnostic and prognostic biomarkers of Alzheimer's disease, and in recent years, there has been an explosive increase of effort aimed at identifying such markers," the authors write as background information in the article. "It has been previously argued that, ...

Asthma medication may benefit patients with multiple sclerosis

2010-09-13

Adding albuterol, a compound commonly used to treat asthma and other respiratory diseases, to an existing treatment for patients with multiple sclerosis appears to improve clinical outcomes, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals. Multiple sclerosis (MS) is a chronic inflammatory disease characterized by the degeneration of myelin, which coats nerve cells in the white matter of the central nervous system. Patients with the condition have been found to have elevated levels of interleukin-12, a biological ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes